Angelo P.
- Country
- Italy
- Department
- 4116: U.O.C. di Urologia
Research Overview
- Phase 3 Randomized Trial of Intravesical Erdafitinib Delivery System vs. Single-Agent Chemotherapy in FGFR+ Intermediate-Risk Non-Muscle Invasive Bladder Cancer
- Evaluation of Intravesical ONCOFID-P-B (Paclitaxel Obaluronate) in BCG-Unresponsive Carcinoma in Situ of the Bladder with or without Ta-T1 Papillary Disease
- (21492 ARASTEP) A randomized, double-blind, placebo-controlled Phase 3 study of darolutamide plus androgen deprivation therapy (ADT) compared with placebo plus ADT in patients with high-risk biochemical recurrence (BCR) of prostate cancer
Data & Insights
Has run more than one trial at 82 of 258 partner sites.
Specializations
Bladder Cancer Research
Specializes in investigating novel treatments for non-muscle invasive bladder cancer, with particular focus on patients exhibiting FGFR gene alterations. Explores intravesical therapeutic approaches for enhanced treatment delivery.
- FGFR-positive bladder cancer
- Intravesical therapy administration
- Targeted treatment approaches
Examines innovative therapeutic solutions for treatment-resistant bladder conditions, including carcinoma in situ cases unresponsive to conventional therapies.
Prostate Cancer Interventions
Focuses on advanced therapeutic strategies for biochemically recurrent prostate cancer, investigating combination treatments involving androgen deprivation therapy.
- Hormone therapy combinations
- PSA-elevated disease management
- Recurrence prevention strategies
Evaluates long-term therapeutic interventions using PSMA PET/CT imaging for monitoring treatment effectiveness.
Treatment-Resistant Urological Cancers
Investigates therapeutic options for BCG-unresponsive bladder conditions, with emphasis on novel intravesical treatments for patients who have not responded to standard therapies.
- Alternative treatment pathways
- Therapy resistance management
- Innovative drug delivery methods
Explores response rates and therapeutic outcomes in complex urological cancer cases requiring specialized intervention approaches.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.